Across TCGA pan-cancer cohorts, TCEAL4P1 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of TCEAL4P1’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where TCEAL4P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types TCEAL4P1 is over-expressed in tumor, although a few such as LUAD and THCA show the opposite, repressed pattern.

KIRC, LUAD, and THCA are the cancer types where TCEAL4P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in TCEAL4P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	+0.055	.005	7	view →
LUAD	Female	All	−0.034	.013	2	view →
THCA	All	II,III,IV	−0.023	.048	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: TCEAL4P1 RNA expression & survival · all TCEAL4P1 data types